580 related articles for article (PubMed ID: 33513412)
1. Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis.
Cao B; Chen Y; Ren Z; Pan Z; McIntyre RS; Wang D
Neurosci Biobehav Rev; 2021 Apr; 123():203-214. PubMed ID: 33513412
[TBL] [Abstract][Full Text] [Related]
2. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings.
Noyan H; Erdağ E; Tüzün E; Yaylım İ; Küçükhüseyin Ö; Hakan MT; Gülöksüz S; Rutten BPF; Saka MC; Atbaşoğlu C; Alptekin K; van Os J; Üçok A
Schizophr Res; 2021 Mar; 229():27-37. PubMed ID: 33609988
[TBL] [Abstract][Full Text] [Related]
3. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
4. The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.
Almulla AF; Vasupanrajit A; Tunvirachaisakul C; Al-Hakeim HK; Solmi M; Verkerk R; Maes M
Mol Psychiatry; 2022 Sep; 27(9):3679-3691. PubMed ID: 35422466
[TBL] [Abstract][Full Text] [Related]
5. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
[TBL] [Abstract][Full Text] [Related]
6. Effect of immune activation on the kynurenine pathway and depression symptoms - A systematic review and meta-analysis.
Hunt C; Macedo E Cordeiro T; Suchting R; de Dios C; Cuellar Leal VA; Soares JC; Dantzer R; Teixeira AL; Selvaraj S
Neurosci Biobehav Rev; 2020 Nov; 118():514-523. PubMed ID: 32853625
[TBL] [Abstract][Full Text] [Related]
7. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
[TBL] [Abstract][Full Text] [Related]
8. The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
Wang Y; Fang X; Wang G; Tang W; Liu S; Yang Y; Chen J; Ling Y; Zhou C; Zhang X; Zhang C; Su KP
Brain Behav Immun; 2023 Oct; 113():1-11. PubMed ID: 37353059
[TBL] [Abstract][Full Text] [Related]
9. The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis.
Ou W; Chen Y; Ju Y; Ma M; Qin Y; Bi Y; Liao M; Liu B; Liu J; Zhang Y; Li L
J Affect Disord; 2023 Oct; 339():624-632. PubMed ID: 37467793
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine pathway in depression: A systematic review and meta-analysis.
Ogyu K; Kubo K; Noda Y; Iwata Y; Tsugawa S; Omura Y; Wada M; Tarumi R; Plitman E; Moriguchi S; Miyazaki T; Uchida H; Graff-Guerrero A; Mimura M; Nakajima S
Neurosci Biobehav Rev; 2018 Jul; 90():16-25. PubMed ID: 29608993
[TBL] [Abstract][Full Text] [Related]
11.
Pearce BD; Massa N; Goldsmith DR; Gandhi ZH; Hankus A; Alrohaibani A; Goel N; Cuthbert B; Fargotstein M; Barr DB; Panuwet P; Brown VM; Duncan E
Front Psychiatry; 2020; 11():552743. PubMed ID: 33329089
[No Abstract] [Full Text] [Related]
12. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia.
Chen W; Tian Y; Gou M; Wang L; Tong J; Zhou Y; Feng W; Li Y; Chen S; Liu Y; Wang Z; Pan S; Zhang P; Huang J; Yang X; Li CR; Tian L; Hong LE; Tan Y
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110926. PubMed ID: 38147973
[TBL] [Abstract][Full Text] [Related]
13. The immune-kynurenine pathway in social anxiety disorder.
Butler MI; Long-Smith C; Moloney GM; Morkl S; O'Mahony SM; Cryan JF; Clarke G; Dinan TG
Brain Behav Immun; 2022 Jan; 99():317-326. PubMed ID: 34758380
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
Linderholm KR; Skogh E; Olsson SK; Dahl ML; Holtze M; Engberg G; Samuelsson M; Erhardt S
Schizophr Bull; 2012 May; 38(3):426-32. PubMed ID: 20729465
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.
Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A
Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497
[TBL] [Abstract][Full Text] [Related]
16. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
[TBL] [Abstract][Full Text] [Related]
17. Kynurenine pathway metabolites are associated with gray matter volume in subjects with schizophrenia.
Zhou S; Huang Y; Kuang Q; Yan S; Li H; Wu K; Wu F; Huang X
Front Psychiatry; 2022; 13():941479. PubMed ID: 36016974
[TBL] [Abstract][Full Text] [Related]
18. The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder.
Öztürk M; Yalın Sapmaz Ş; Kandemir H; Taneli F; Aydemir Ö
Int J Clin Pract; 2021 Apr; 75(4):e13739. PubMed ID: 32997876
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
Ryan KM; Allers KA; McLoughlin DM; Harkin A
Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
